Thrombotic Microangiopathy Caused by Gemcitabine in a Patient with Duodenal Cancer

• Main Authors: Jeyachandran Dhanapriya (Author), Sankarakumar GaneshAravind (Author), Thanigachalam Dineshkumar (Author), Ramanathan Sakthirajan (Author), Balasubramaniyan T (Author), Natarajan Gopalakrishnan (Author)
• Format: Book
• Published: Archives of Clinical Nephrology - Peertechz Publications, 2017-03-27.
• Subjects: Case Report
• Online Access: Connect to this object online.

<p>Gemcitabine (2',2'-difl uorodeoxycytidine) is a potent pyrimidine antimetabolite and was introduced in 1987. It is commonly used for various tumors including non-small cell lung cancer, pancreatic cancer, breast cancer, ovarian can cer and renal cell carcinoma at advanced stages....